Longer-term data fail to clear concern over Takeda’s dengue vaccine

An additional six months of data from a late-stage trial of Takeda Pharmaceutical Co’s experimental dengue vaccine again showed it failed to protect against one of the four types of the virus in an important patient group, researchers said on Saturday.


Reuters: Health News

Bangladesh struggles with worst outbreak of dengue fever

Bangladesh is grappling with its worst outbreak of dengue fever, with hospitals packed with patients as the disease spreads rapidly in the densely-populated country.


Reuters: Health News